Effect of Gudadimodak in Acidity

An Etiopathological Study of Urdhwaga Amlapitta w.s.r. to GERD(Gastro Esophageal Reflux Diseases) And Therapeutical Effect of Gudadimodak - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067202

Enrollment

Registered

2024-05-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. presence of cardinal symptoms of urdhwaga amlapitta.

Exclusion criteria

Exclusion criteria: 1. patience with peptic ulcer duodenal ulcer, cardiac disorder, hypertention, DM, CKD

Design outcomes

Primary

Measure	Time frame
1.Improvement in Signs & Symptoms of Urdhwaga Amlapitta (Acidity) Timepoint: 2 weeks	—

Secondary

Measure	Time frame
1.Improvement in Signs & Symptoms of Urdhwaga Amlapitta (Acidity) Timepoint: 4 Weeks	—

Countries

India

Contacts

Public ContactDr Man Mohan Sharma

Madan Mohan Malviya Government Ayurved COllege

drmmsharma72@gmail.com8426050055

Outcome results